BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22004871)

  • 1. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice.
    Ho JH; Tseng TC; Ma WH; Ong WK; Chen YF; Chen MH; Lin MW; Hong CY; Lee OK
    Cell Transplant; 2012; 21(5):997-1009. PubMed ID: 22004871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice.
    Wang HS; Shyu JF; Shen WS; Hsu HC; Chi TC; Chen CP; Huang SW; Shyr YM; Tang KT; Chen TH
    Cell Transplant; 2011; 20(3):455-66. PubMed ID: 20719086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of insulin-producing cells derived from endometrial mesenchymal stem-like cells.
    Li HY; Chen YJ; Chen SJ; Kao CL; Tseng LM; Lo WL; Chang CM; Yang DM; Ku HH; Twu NF; Liao CY; Chiou SH; Chang YL
    J Pharmacol Exp Ther; 2010 Dec; 335(3):817-29. PubMed ID: 20855446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment.
    Chang C; Niu D; Zhou H; Zhang Y; Li F; Gong F
    Cytotherapy; 2008; 10(8):796-805. PubMed ID: 18979304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-derived mesenchymal stem cells ameliorate STZ-induced pancreas damage in type 1 diabetes.
    Li YY; Liu HH; Chen HL; Li YP
    Biomed Mater Eng; 2012; 22(1-3):97-103. PubMed ID: 22766707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells adopt beta-cell fate upon diabetic pancreatic microenvironment.
    Chang C; Wang X; Niu D; Zhang Z; Zhao H; Gong F
    Pancreas; 2009 Apr; 38(3):275-81. PubMed ID: 19066494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
    Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
    J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
    Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
    PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells.
    Lin P; Chen L; Yang N; Sun Y; Xu YX
    Transplant Proc; 2009 Jun; 41(5):1891-3. PubMed ID: 19545751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway.
    Fang Y; Tian X; Bai S; Fan J; Hou W; Tong H; Li D
    Int J Mol Med; 2012 Jul; 30(1):85-92. PubMed ID: 22552764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
    Nagaishi K; Ataka K; Echizen E; Arimura Y; Fujimiya M
    Hepatology; 2014 May; 59(5):1816-29. PubMed ID: 24375439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
    Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.
    Urbán VS; Kiss J; Kovács J; Gócza E; Vas V; Monostori E; Uher F
    Stem Cells; 2008 Jan; 26(1):244-53. PubMed ID: 17932424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.